COVID-19 Update: Focus on High Risk MDS and Secondary AML Patients | Aplastic Anemia & MDS International Foundation

COVID-19 Update: Focus on High Risk MDS and Secondary AML Patients

Presenter(s): 
Topic(s): 
COVID-19
Myelodysplastic Syndromes (MDS)
Acute Myeloid Leukemia (AML)
Presentation Date: 
Tuesday, March 31, 2020

This webinar with Gail Roboz, MD, addresses the concerns of high-risk MDS or secondary AML patients and their caregivers and reviews the precautions they should be taking to protect their health. Patients, families and caregiver questions are included at the end of the presentation.